HIV pre-exposure prophylaxis (PrEP) can either be used daily or as an event-based dosing (EBD) regimen by men who have sex with men (MSMs) having condomless anal sex to prevent HIV transmission; however, clinicians with expertise delivering daily PrEP often lack confidence delivering EBD–PrEP.
There were 551 MSMs seen who were eligible for PrEP in the study period, of which 448 were prescribed PrEP (64 declined, 2 stopped, 8 new patients and 29 repeat attenders accessed PrEP from another source). The median age of PrEP users was 37 years (IQR=29–48). Overall, 94/448 (21%, 95%…